Skip to main content
. 2019 Jul 10;39(28):5440–5451. doi: 10.1523/JNEUROSCI.0265-19.2019

Figure 7.

Figure 7.

Effects of inhibitors of PK signaling pathways on the NKA-sAHPs. a, Bar diagram represents the effects of various blockers of signaling pathways, applied for ≥1 h, on the amplitudes of the NKA-sAHPs. Amplitude values are normalized with respect to mean control value (n = 102) and depicted as mean ± SEM. The blockers applied are H89 (n = 10), KT5823 (n = 17), ODQ (n = 11), chelerythrine (n = 18), and KT5823 together with chelerythrine (n = 16). Statistical significance was tested with one-way ANOVA (α = 0.05) with two-sided Dunnett t test. b, Same as in a, but for NKA-sAHPs areas. Neither one of the blockers applied affected the amplitude or area of the NKA-sAHPs, ns, not significant.